Qiming Venture Partners USA raises $260m for third fund

The fund will invest in early-stage therapeutics and healthcare tech companies in the U.S. and the EU.

2 June 2022•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles